Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Buprenorphine

Buprenorphine in Trinidad and Tobago: not individually verified

Also known as: subutex

Not individually verified

We have not confirmed that Buprenorphine specifically is scheduled in Trinidad and Tobago, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. No printed entry for buprenorphine was found in the 2016 consolidation's First, Second and Fourth Schedules and the Orders LN 343/2019, LN 345/2019, LN 346/2019, LN 166/2023, LN 131/2024 and LN 293/2026, read as at 3 October 2026; a search for buprenorph returned no hit in any of them. The nearest text is in item 1 of the First Schedule, the opium poppy item: entry (6), «Thebaine, and their preparations, derivatives and salts, as» for example, and the entries that follow it, which include etorphine and «Actorphine». Whether those entries are examples under entry (6) or further entries of item 1 is not settled by the print. Whether buprenorphine is a thebaine derivative in that item's sense is a chemical judgment the Schedule does not make by naming it, and this cell does not make it either. The substance is not listed by name in any Schedule read, as at 3 October 2026, the date the instruments were read.

Confirm directly with Trinidad and Tobago’s national drug authority or your own embassy before you rely on anything.

What Trinidad and Tobago HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.